FormFactor's loss under GAAP for 9 months of 2020 amounted to $41.826 million, a 4-fold increase from $10.137 million in the previous year. The Group did not receive any revenue in the reporting period. A year earlier, it was $93.113 million.
FormFactor's loss under GAAP for 9 months of 2020 amounted to $41.826 million, a 4-fold increase from $10.137 million in the previous year. The Group did not receive any revenue in the reporting period. A year earlier, it was $93.113 million. 
ir.formatherapeutics.com
English (US) 